Novel uses of immunohistochemistry in the diagnosis and classification of soft tissue tumors (Q27001114)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24384853%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

author name string

Jason L Hornick

series ordinal

1

1 reference

language of work or name

1 reference

January 2014

1 reference

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24384853%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

volume

27 Suppl 1

2 references

PubMed

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24384853%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

page(s)

S47-63

2 references

PubMed

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24384853%20AND%20SRC:MED&resulttype=core&format=json

Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas

13 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2013.177

SATB2 is a multifunctional determinant of craniofacial patterning and osteoblast differentiation

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2013.177

The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2013.177

Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2013.177

Ano1 is a selective marker of interstitial cells of Cajal in the human and mouse gastrointestinal tract

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2013.177

MyoD1 and myogenin expression in human neoplasia: a review and update

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

Are myogenin and myoD1 expression specific for rhabdomyosarcoma? A study of 150 cases, with emphasis on spindle cell mimics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

Sclerosing rhabdomyosarcoma in adults: report of four cases of a hyalinizing, matrix-rich variant of rhabdomyosarcoma that may be confused with osteosarcoma, chondrosarcoma, or angiosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

Pleomorphic rhabdomyosarcoma in adults: a clinicopathologic study of 38 cases with emphasis on morphologic variants and recent skeletal muscle-specific markers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

Expression of Fli-1, a nuclear transcription factor, distinguishes vascular neoplasms from potential mimics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

Utility of the immunohistochemical detection of FLI-1 expression in round cell and vascular neoplasm using a monoclonal antibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

ERG expression in epithelioid sarcoma: a diagnostic pitfall

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

Clinical applications of novel ERG immunohistochemistry in prostate cancer diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

Brachyury, SOX-9, and podoplanin, new markers in the skull base chordoma vs chondrosarcoma differential: a tissue microarray-based comparative analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

Specificity of brachyury in the distinction of chordoma from clear cell renal cell carcinoma and germ cell tumors: a study of 305 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

Brachyury expression in extra-axial skeletal and soft tissue chordomas: a marker that distinguishes chordoma from mixed tumor/myoepithelioma/parachordoma in soft tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

Role of the transcription factor T (brachyury) in the pathogenesis of sporadic chordoma: a genetic and functional-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

T (brachyury) gene duplication confers major susceptibility to familial chordoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

A common single-nucleotide variant in T is strongly associated with chordoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

Value of SOX10 immunostaining in tumor diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

SOX10 expression distinguishes desmoplastic melanoma from its histologic mimics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

Neural crest transcription factor Sox10 is preferentially expressed in triple-negative and metaplastic breast carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

SOX10 is a novel marker of acinus and intercalated duct differentiation in salivary gland tumors: a clue to the histogenesis for tumor diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

Identification of SATB2 as the cleft palate gene on 2q32-q33.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

SATB2 is a novel marker of osteoblastic differentiation in bone and soft tissue tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

SATB2 in Combination With Cytokeratin 20 Identifies Over 95% of all Colorectal Carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

Specific mutations in the beta-catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

Nuclear beta-catenin expression distinguishes deep fibromatosis from other benign and malignant fibroblastic and myofibroblastic lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

The diagnostic value of beta-catenin immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

Beta-catenin immunohistochemistry separates mesenteric fibromatosis from gastrointestinal stromal tumor and sclerosing mesenteritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

Immunohistochemistry for beta-catenin in the differential diagnosis of spindle cell lesions: analysis of a series and review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

Well-differentiated and dedifferentiated liposarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: a comparative analysis of 559 soft tissue neoplasms with genetic data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

Diagnostic utility of p16, CDK4, and MDM2 as an immunohistochemical panel in distinguishing well-differentiated and dedifferentiated liposarcomas from other adipocytic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

Inflammatory malignant fibrous histiocytomas and dedifferentiated liposarcomas: histological review, genomic profile, and MDM2 and CDK4 status favour a single entity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

INI1-deficient tumors: diagnostic features and molecular genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

Immunohistochemical analysis of hSNF5/INI1 in pediatric CNS neoplasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

Epithelioid sarcoma: a clinicopathologic and immunohistochemical analysis of 106 cases from the French sarcoma group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

Hybrid schwannoma/perineurioma: clinicopathologic analysis of 42 distinctive benign nerve sheath tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

INI1 and GLUT-1 expression in epithelioid sarcoma and its cutaneous neoplastic and nonneoplastic mimics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

Epithelioid sarcoma is associated with a high percentage of SMARCB1 deletions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

SMARCB1/INI1 inactivation in renal medullary carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

Succinate dehydrogenase-deficient tumors: diagnostic advances and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

Succinate dehydrogenase-deficient GISTs: a clinicopathologic, immunohistochemical, and molecular genetic study of 66 gastric GISTs with predilection to young age

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

SDHB immunohistochemistry: a useful tool in the diagnosis of Carney-Stratakis and Carney triad gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

"Pediatric-type" gastrointestinal stromal tumors in adults: distinctive histology predicts genotype and clinical behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

Loss of SDHA expression identifies SDHA mutations in succinate dehydrogenase-deficient gastrointestinal stromal tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

Immunohistochemical loss of succinate dehydrogenase subunit A (SDHA) in gastrointestinal stromal tumors (GISTs) signals SDHA germline mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

Renal tumors associated with germline SDHB mutation show distinctive morphology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

A distinctive subset of PEComas harbors TFE3 gene fusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

Expression of ERG, an Ets family transcription factor, identifies ERG-rearranged Ewing sarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

Expression of ALK1 and p80 in inflammatory myofibroblastic tumor and its mesenchymal mimics: a study of 135 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

Anaplastic lymphoma kinase expression in inflammatory pseudotumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

Anaplastic lymphoma kinase status in rhabdomyosarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

Combined use of ALK immunohistochemistry and FISH for optimal detection of ALK-rearranged lung adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

Comprehensive genetic analysis identifies a pathognomonic NAB2/STAT6 fusion gene, nonrandom secondary genomic imbalances, and a characteristic gene expression profile in solitary fibrous tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

Meningeal hemangiopericytoma and solitary fibrous tumors carry the NAB2-STAT6 fusion and can be diagnosed by nuclear expression of STAT6 protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

The utility of discovered on gastrointestinal stromal tumor 1 (DOG1) antibody in surgical pathology-the GIST of it.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

Monoclonal antibody DOG1.1 shows higher sensitivity than KIT in the diagnosis of gastrointestinal stromal tumors, including unusual subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

TLE1 as a diagnostic immunohistochemical marker for synovial sarcoma emerging from gene expression profiling studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

Immunohistochemical staining for TLE1 distinguishes synovial sarcoma from histologic mimics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

Prospective evaluation of TLE1 as a diagnostic immunohistochemical marker in synovial sarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

TLE1 expression is not specific for synovial sarcoma: a whole section study of 163 soft tissue and bone neoplasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

FUS-CREB3L2/L1-positive sarcomas show a specific gene expression profile with upregulation of CD24 and FOXL1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

Translocation-positive low-grade fibromyxoid sarcoma: clinicopathologic and molecular analysis of a series expanding the morphologic spectrum and suggesting potential relationship to sclerosing epithelioid fibrosarcoma: a study from the French Sarco

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

Clinicopathologic and molecular genetic characterization of low-grade fibromyxoid sarcoma, and cloning of a novel FUS/CREB3L1 fusion gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

MUC4 is a highly sensitive and specific marker for low-grade fibromyxoid sarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

Assessment of MUC4 expression in primary bone tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

Expression of ERG, an Ets family transcription factor, distinguishes cutaneous angiosarcoma from histological mimics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

MUC4 Is a Sensitive and Extremely Useful Marker for Sclerosing Epithelioid Fibrosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

ERG Transcription Factor as an Immunohistochemical Marker for Vascular Endothelial Tumors and Prostatic Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

ERG protein expression in human tumors detected with a rabbit monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

7 January 2021

ERG and FLI1 protein expression in epithelioid sarcoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

7 January 2021

Sox10: a pan-schwannian and melanocytic marker

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

7 January 2021

Sox10 and S100 in the diagnosis of soft-tissue neoplasms

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

7 January 2021

Molecular abnormalities of the p53 pathway in dedifferentiated liposarcoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

7 January 2021

Coordinated expression and amplification of the MDM2, CDK4, and HMGI-C genes in atypical lipomatous tumours

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

7 January 2021

Detection of MDM2-CDK4 amplification by fluorescence in situ hybridization in 200 paraffin-embedded tumor samples: utility in diagnosing adipocytic lesions and comparison with immunohistochemistry and real-time PCR

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

7 January 2021

Immunohistochemical analysis of hSNF5/INI1 distinguishes renal and extra-renal malignant rhabdoid tumors from other pediatric soft tissue tumors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

7 January 2021

Loss of INI1 expression is characteristic of both conventional and proximal-type epithelioid sarcoma.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

7 January 2021

Renal medullary carcinoma: rhabdoid features and the absence of INI1 expression as markers of aggressive behavior

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

7 January 2021

Loss of succinate dehydrogenase subunit B (SDHB) expression is limited to a distinctive subset of gastric wild-type gastrointestinal stromal tumours: a comprehensive genotype-phenotype correlation study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

7 January 2021

Immunohistochemistry for SDHB divides gastrointestinal stromal tumors (GISTs) into 2 distinct types

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

7 January 2021

SDHA mutations in adult and pediatric wild-type gastrointestinal stromal tumors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

7 January 2021

Loss of expression of SDHA predicts SDHA mutations in gastrointestinal stromal tumors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

7 January 2021

Mapping of succinate dehydrogenase losses in 2258 epithelial neoplasms

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

7 January 2021

Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

7 January 2021

Immunohistochemical detection of FLI-1 protein expression: a study of 132 round cell tumors with emphasis on CD99-positive mimics of Ewing's sarcoma/primitive neuroectodermal tumor.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

7 January 2021

Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor: a comparative immunohistochemical study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

7 January 2021

Immunohistochemistry is a reliable screening tool for identification of ALK rearrangement in non-small-cell lung carcinoma and is antibody dependent

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

7 January 2021

Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

7 January 2021

TLE1 is a robust diagnostic biomarker for synovial sarcomas and correlates with t(X;18): analysis of 319 cases

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.177

7 January 2021

10.1038/MODPATHOL.2013.177

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24384853%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

13 June 2020

1023014049

0 references

Fatcat ID

release_27mdbobtdbfz5nng7vaqxi6qzu

0 references

2 references